These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 35214051)

  • 1. RNA-Based Strategies for Cell Reprogramming toward Pluripotency.
    Bailly A; Milhavet O; Lemaitre JM
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues.
    Alle Q; Le Borgne E; Milhavet O; Lemaitre JM
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.
    Menendez JA; Vellon L; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A
    Cell Cycle; 2011 Nov; 10(21):3658-77. PubMed ID: 22052357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
    Walia B; Satija N; Tripathi RP; Gangenahalli GU
    Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming.
    Spyrou J; Gardner DK; Harvey AJ
    Stem Cells; 2019 Aug; 37(8):1042-1056. PubMed ID: 31042329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the reprogramming of somatic cells.
    Ma T; Xie M; Laurent T; Ding S
    Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK-STAT3 and somatic cell reprogramming.
    Tang Y; Tian XC
    JAKSTAT; 2013 Oct; 2(4):e24935. PubMed ID: 24470976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of CITED2 prior to reprogramming, promotes and homogenises the conversion of somatic cells into induced pluripotent stem cells.
    Charneca J; Matias AC; Escapa AL; Fernandes C; Alves A; Santos JMA; Nascimento R; Bragança J
    Exp Cell Res; 2017 Sep; 358(2):290-300. PubMed ID: 28684114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells.
    Lorenzo IM; Fleischer A; Bachiller D
    Stem Cell Rev Rep; 2013 Aug; 9(4):435-50. PubMed ID: 23104133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Insight into Reprogramming Barriers to iPSC Generation.
    Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in regulation of pluripotency and somatic cell reprogramming: small molecule with big impact.
    Wang T; Shi SB; Sha HY
    RNA Biol; 2013 Aug; 10(8):1255-61. PubMed ID: 23921205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
    Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
    J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.
    Chen T; Shen L; Yu J; Wan H; Guo A; Chen J; Long Y; Zhao J; Pei G
    Aging Cell; 2011 Oct; 10(5):908-11. PubMed ID: 21615676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation.
    Prasad A; Manivannan J; Loong DT; Chua SM; Gharibani PM; All AH
    Regen Med; 2016 Mar; 11(2):181-91. PubMed ID: 26857809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elixir of Life: Thwarting Aging With Regenerative Reprogramming.
    Beyret E; Martinez Redondo P; Platero Luengo A; Izpisua Belmonte JC
    Circ Res; 2018 Jan; 122(1):128-141. PubMed ID: 29301845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular trajectories and molecular mechanisms of iPSC reprogramming.
    Apostolou E; Stadtfeld M
    Curr Opin Genet Dev; 2018 Oct; 52():77-85. PubMed ID: 29925040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
    Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.